Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft drinks may play a role in the development of diabetes. Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and even modulate incretin release. However, it is unclear, if these findings are valid for all kinds of AS, as they are chemically different. Furthermore, data on human subjects are sparse and controversial. The investigators will therefore conduct 7 consecutive single oral stimulations with glucose or AS alone or a combination. Three different AS will be tested.
Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft drinks may play a role in the development of diabetes. Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and even modulate incretin release. However, it is unclear, if these findings are valid for all kinds of AS, as they are chemically different. Up to now, no single study has ever compared metabolic responses to different AS in the same subjects. Furthermore, data on human subjects are sparse and controversial. This is partially explained by different methodical approaches such as intragastral/intraduodenal application of AS, rather than conventional oral consumption. The investigators will therefore conduct 7 consecutive single oral stimulations with glucose or AS alone or a combination. Three different AS will be tested: saccharin, aspartame and sucralose.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
14
oral stimulation with glucose, AS or glucose+AS in fasted state, blood samples from fasted state up to 120 min post-ingestion
German Institut for Human Nutrition; Department for Clinical Nutrition
Bergholz-Rehbrücke, Brandenburg, Germany
change in GIP release
comparison between all seven interventions
Time frame: 120 mins
change in GLP-1 release
comparison between all seven interventions
Time frame: 120 mins
change in GLP-2 release
comparison between all seven interventions
Time frame: 120 mins
change in PYY release
comparison between all seven interventions
Time frame: 120 mins
change in insulin release
comparison between all seven interventions
Time frame: 120 mins
change in combined blood levels of glucose and insulin, expressed in calculated indices for insulin secretion
comparison between all seven interventions
Time frame: 120 mins
change in combined blood levels of glucose and insulin, expressed in calculated indices for insulin sensitivity
comparison between all seven interventions
Time frame: 120 mins
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.